Filing Flows › Praxis Precision Medicines (PRAX) › Q4 2024 › vs Q4 2023
Praxis Precision Medicines (PRAX) Q4 2024 vs Q4 2023 (year over year)
Praxis Precision Medicines's revenue rose $6.9M (14×) from $515K in Q4 2023 to $7.5M in Q4 2024.
Praxis Precision Medicines, Q4 2024: revenue $7.5M (14× year over year), operating margin -857.0%, net loss $58.7M, operating cash flow −$56.1M. The chart draws each line against Q4 2023, the increases inside each band.
Every line
| Line | Q4 2024 | Q4 2023 | Change | % |
|---|---|---|---|---|
| Revenue | $7.5M | $515K | $6.9M | 14× |
| Other income, net | $5.3M | $928K | $4.3M | +469% |
| Net loss | $58.7M | $26.9M | $31.8M | +118% |
| Costs & expenses | $71.4M | $28.3M | $43.1M | +152% |
| Operating costs | $71.4M | $28.3M | $43.1M | +152% |
| Research & development | $56.3M | $18.4M | $37.9M | +206% |
| General & admin | $15.1M | $9.9M | $5.2M | +52% |
| Operating cash sources | $64.7M | $29.7M | $35.0M | +118% |
| Depreciation | $47K | $111K | −$64K | -58% |
| Share-based compensation | $8.6M | $5.7M | $2.8M | +50% |
| Cash used in operations | $56.1M | $23.9M | $32.3M | +135% |
| Net loss absorbed | $58.7M | $26.9M | $31.8M | +118% |
| Working capital & other | $6.1M | $2.8M | $3.2M | +115% |
Questions
How much did Praxis Precision Medicines's revenue grow year over year in Q4 2024?
Praxis Precision Medicines's revenue rose $6.9M (14×) from $515K in Q4 2023 to $7.5M in Q4 2024.